Pharmaceutical stocks have been a safe harbor in a choppy stock market, and for good reason.

Twitter is proving that smaller may be better, even in social media, as purging users makes Twitter’s advertising business more healthy.

The diverging fates of Barclays and Deutsche Bank are connected by the amount of cheap funding they can offer clients.

Shares in Samsung and SK Hynix have suffered despite both companies reporting record earnings.

The company’s 15% growth is a significant number for a business generating more than $200 billion in annual sales, but it is not the kind of growth its investors have been banking on.

News of the eurozone’s demise is exaggerated, but that may not offer much comfort to stock investors.

PayPal results suggest eBay’s recent marketplace growth spurt may be short lived.

The environment that the Federal Reserve envisions for the economy wouldn’t be all that friendly for stocks.

Shares in major casino operators in the world’s largest gambling market have been tumbling, but it isn’t time for investors to up their bets.

Panic in the stock market is officially over—at least according to derivatives markets.

Big footprints in emerging markets are often considered the crown jewels of European consumer-products giants like Nestlé and Unilever. But the downside is apparent.

Beating the crowds at Disney World early is going to cost you.

The merger of Ensco and Rowan makes sense, but the rally in their shares so far this year is premature because there is no sign of improving rates for their rigs this year or next, despite higher crude prices.

The other CEO announcement on Monday wasn’t quite as exciting.

Many were surprised to see that Coca-Cola, the world’s largest beverage company, is considering dipping its toes into the cannabis market.

The coming ‘Captain Marvel' marks an overdue milestone in the Marvel universe.

People in the Carolinas are about to rediscover the difference between the damage a storm causes and what is covered by insurance. While wind damage is well covered by insurers, flood damage is absent from most policies.

Despite the fabled co-founder’s retirement, Jack Ma will still have influence at Alibaba. But the real question for investors is whether his departure means the company’s best days are behind it.

The bank’s stock price is likely to remain under pressure as Chinese conglomerate HNA prepares to sell its 7.6% stake. But short-term pain should give way to a better longer-term foundation for the stock.

Investors applauded and then cooled on trucking firm Knight-Swift following the merger that created it, but they should take another look.

The e-commerce giant is on track to be tech’s largest company in both market value and sales.

The food-delivery company has a highly successful app but makes no profit. A $55 billion valuation looks a stretch, especially at a bad time for Chinese tech stocks.

The bilateral trade deal with Mexico and any subsequent agreement with Canada may create some frictions for companies and consumers, but it is a relief compared to what might have been.

Apple and Google’s app store commissions form a lucrative revenue stream that most app developers can’t sidestep in the way Netflix is attempting. That could spur regulators to take a closer look.

Streaming service is so far ahead of the competition and knows how to please its customers so well that it will be very hard to dislodge.

A promising rebound in loan growth now appears to be fading. That could become an issue, especially for small and midsize lenders.

Lei Jun, founder of Chinese smartphone maker Xiaomi, just enjoyed one of the biggest paydays in global corporate history. He could be in for another jackpot soon.

Concerns about slowing growth of printing supplies offsets strong PC sales for tech giant.

The world’s second-largest fashion chain by sales has fallen behind as consumers have moved online. Despite a big decline, the stock hasn’t priced in the new reality.

This fall the industry will launch a series of major first-person shooters, while “Fortnite” is poised to begin a new season. That may prove to be a bit too much action for some game publishers.

Food company Smucker has made smart moves to adjust its portfolio, but without boosting its core brands the stock will keep struggling.

The reason to buy shares in Abbott Labs is simple:The company is growing its top line faster than just about any health-care company of comparable size and since it doesn’t sell pharmaceuticals in the U.S., it is relatively insulated from regulatory risk.

The country’s stock market is close to all-time highs, while its currency is at all-time lows versus the dollar.

A volatile crypto market has been a distraction for the chip maker—and its investors.

The department store has solid earnings and raises guidance, but that isn’t enough for investors after a big stock run.